A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Anadys Pharmaceuticals

About Anadys Pharmaceuticals:

Anadys discovers, develops, and commercializes novel small molecule medicines for the treatment of chronic viral infections and bacterial infections.

Anadys' primary therapeutic focus encompasses the anti-infective market, including antivirals and antibacterials, which represents over $40 billion in annual sales with a significant need for novel and improved therapeutics.

Pipeline Chart for Anadys

Pipeline -- Clinical Trials:

Isatoribine (ANA245) Hepatitis C
ANA 380 Hepatitis B
Isatoribine (ANA245) Addition Indications
Oral Prodrug ANA971 Additional Indications
Oral Prodrug ANA975Hepatitis C


More on Anadys Pharmaceuticals

Home Page

Key Statistics fo Anadys

Basic Chart for Anadys

Analyst Opinion

Analysts Estimates

Biotech100 Index
What are the Requirements to be listed in the Biotech100 Index?
See the Biotech100 List

Sponsored Links

Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
Small Cap Stocks
Stocks and Bonds
Biotech100 Index

Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?




Copyright 2005 BIOTECH100.COM. All rights reserved.